HALO logo
halo search icon
Septerna, Inc.
Septerna, Inc.
SEPN · NAS

Septerna, Inc.

US$27.92

Price Arrow-0.09 (-0.321%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Septerna, Inc. Overview

SEPN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

About SEPN

icon

Website

Septerna, Inc.

icon

Telephone

1.650.338.3533

icon

Address

250 East Grand Avenue, South San Francisco, CA 94080

Description

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.

SEPN Price Chart

Key Stats

Market Cap

US$1.26B

PE

86.20

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 8.86 - 32.63

Trade Value (12mth)

US$1,653,081.00

1 week

3.93%

1 month

8.31%

YTD

0.11%

1 year

195.46%

All time high

32.63

Key Fundamentals

EPS 3 yr Growth

67.60%

EBITDA Margin

-172.30%

Operating Cashflow

$110m

Free Cash Flow Return

26.00%

ROIC

-11.50%

Interest Coverage

0.00

Quick Ratio

4.70

Other Data

Shares Outstanding (Fully Diluted)

45m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SEPN Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
12 May 26

SEPN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.01-1.62-1.1locklocklock
EPS (Fully Diluted)
$locklocklocklock0.01-1.62-1.1locklocklock
Growth
%locklocklocklock102-12,071.931.7locklocklock
PE
XlocklocklocklockN/AN/A86.2locklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Septerna, Inc. (SEPN:NAS)?
Halo FAQ
The current share price of Septerna, Inc. (SEPN:NAS) is USD$27.92.
What is the 52-week high share price for Septerna, Inc. (SEPN:NAS)?
Halo FAQ
The 52-week high share price for Septerna, Inc. (SEPN:NAS) is USD$32.63.
What is the 52-week low share price for Septerna, Inc. (SEPN:NAS)?
Halo FAQ
The 52-week low share price for Septerna, Inc. (SEPN:NAS) is USD$8.86.
What is the dividend yield for Septerna, Inc. (SEPN:NAS)?
Halo FAQ
Septerna, Inc. (SEPN:NAS) does not pay a dividend.
What was Septerna, Inc. (SEPN:NAS) last dividend payment?
Halo FAQ
Septerna, Inc. (SEPN:NAS) does not pay a dividend.
What is the franking level for Septerna, Inc. (SEPN:NAS)?
Halo FAQ
Septerna, Inc. (SEPN:NAS) has a franking level of 0.00%.
In which sector is Septerna, Inc. (SEPN:NAS) classified?
Halo FAQ
Septerna, Inc. (SEPN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Septerna, Inc. (SEPN:NAS)?
Halo FAQ
The current P/E ratio for Septerna, Inc. (SEPN:NAS) is 86.20.

See beyond the curve.

One solution for research, investing and portfolio management.